Literature DB >> 19470872

Hypertension prevalence, awareness, treatment, and control in mozambique: urban/rural gap during epidemiological transition.

Albertino Damasceno1, Ana Azevedo, Carla Silva-Matos, António Prista, Domingos Diogo, Nuno Lunet.   

Abstract

The prediction of cardiovascular risk profile trends in low-income countries and timely action to modulate their transitions are among the greatest global health challenges. In 2005 we evaluated a nationally representative sample of the Mozambican population (n=3323; 25 to 64 years old) following the Stepwise Approach to Chronic Disease Risk Factor Surveillance. Prevalence of hypertension (systolic blood pressure > or =140 mm Hg and/or diastolic blood pressure > or =90 mm Hg and/or antihypertensive drug therapy), awareness (having been informed of the hypertensive status by a health professional in the previous year), treatment among the aware (use of antihypertensive medication in the previous fortnight), and control among those treated (blood pressure <140/90 mm Hg) were 33.1% (women: 31.2%; men: 35.7%), 14.8% (women: 18.4%; men: 10.6%), 51.9% (women: 61.1%; men: 33.3%), and 39.9% (women: 42.9%; men: 28.7%), respectively. Urban/rural comparisons are presented as age- and education-adjusted odds ratios (ORs) and 95% CIs. Among women, hypertension (OR: 2.0; 95% CI: 1.2 to 3.0) and awareness (OR: 4.3; 95% CI: 1.9 to 9.5) were more frequent in urban areas. No urban/rural differences were observed in men (hypertension: OR: 1.3, 95% CI: 0.9 to 2.0; awareness: OR: 1.5, 95% CI: 0.5 to 4.7). Treatment prevalence was not significantly different across urban/rural settings (women: OR: 1.4, 95% CI: 0.5 to 4.4; men: OR: 0.3, 95% CI: 0.1 to 1.4). Control was less frequent in urban women (OR: 0.2; 95% CI: 0.0 to 1.0) and more frequent in urban men (OR: 78.1; 95% CI: 2.2 to 2716.6). Our results illustrate the changing paradigms of "diseases of affluence" and the dynamic character of epidemiological transition. The urban/rural differences across sexes support a trend toward smaller differences, emphasizing the need for strategies to improve prevention, correct diagnosis, and access to effective treatment.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19470872     DOI: 10.1161/HYPERTENSIONAHA.109.132423

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  89 in total

1.  High prevalence, low awareness, treatment and control rates of hypertension in Guinea: results from a population-based STEPS survey.

Authors:  A Camara; N M Baldé; M Diakité; D Sylla; E H Baldé; A P Kengne; M D Baldé
Journal:  J Hum Hypertens       Date:  2015-08-27       Impact factor: 3.012

2.  African experiences of humanitarian cardiovascular medicine: the Mozambican experience.

Authors:  Ana Olga Mocumbi
Journal:  Cardiovasc Diagn Ther       Date:  2012-09

Review 3.  Control of hypertension with medication: a comparative analysis of national surveys in 20 countries.

Authors:  Nayu Ikeda; David Sapienza; Ramiro Guerrero; Wichai Aekplakorn; Mohsen Naghavi; Ali H Mokdad; Rafael Lozano; Christopher J L Murray; Stephen S Lim
Journal:  Bull World Health Organ       Date:  2013-09-30       Impact factor: 9.408

4.  Cardiovascular disease: A global problem extending into the developing world.

Authors:  Temilolu Olayinka Aje; Michael Miller
Journal:  World J Cardiol       Date:  2009-12-31

5.  Prevalence of hypertension and diabetes among Ethiopian adults.

Authors:  Lemba D Nshisso; Angela Reese; Bizu Gelaye; Sebelewengel Lemma; Yemane Berhane; Michelle A Williams
Journal:  Diabetes Metab Syndr       Date:  2012-06-05

6.  Body mass index, cardiorespiratory fitness and cardiometabolic risk factors in youth from Portugal and Mozambique.

Authors:  F K dos Santos; A Prista; T N Q F Gomes; D Santos; A Damasceno; A Madeira; P T Katzmarzyk; J A R Maia
Journal:  Int J Obes (Lond)       Date:  2015-06-10       Impact factor: 5.095

7.  Awareness, treatment and control of hypertension in Nepal: findings from the Dhulikhel Heart Study.

Authors:  Biraj M Karmacharya; Rajendra P Koju; James P LoGerfo; Kwun Chuen Gary Chan; Ali H Mokdad; Archana Shrestha; Nona Sotoodehnia; Annette L Fitzpatrick
Journal:  Heart Asia       Date:  2017-01-04

8.  Hypertension prevalence, awareness, treatment and control in Dakar (Senegal).

Authors:  P Duboz; G Boëtsch; L Gueye; E Macia
Journal:  J Hum Hypertens       Date:  2014-01-16       Impact factor: 3.012

Review 9.  Echoes from Gaea, Poseidon, Hephaestus, and Prometheus: environmental risk factors for high blood pressure.

Authors:  Prateek Sharma; Robert D Brook
Journal:  J Hum Hypertens       Date:  2018-06-13       Impact factor: 3.012

10.  Cardiovascular risk in Mozambique: who should be treated for hypertension?

Authors:  Albertino Damasceno; Patrícia Padrão; Carla Silva-Matos; António Prista; Ana Azevedo; Nuno Lunet
Journal:  J Hypertens       Date:  2013-12       Impact factor: 4.844

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.